Literature DB >> 31259490

Amenorrhea: A Systematic Approach to Diagnosis and Management.

David A Klein1, Scott L Paradise1, Rachel M Reeder1.   

Abstract

Menstrual patterns can be an indicator of overall health and self-perception of well-being. Primary amenorrhea, defined as the lifelong absence of menses, requires evaluation if menarche has not occurred by 15 years of age or three years post-thelarche. Secondary amenorrhea is characterized by cessation of previously regular menses for three months or previously irregular menses for six months and warrants evaluation. Clinicians may consider etiologies of amenorrhea categorically as outflow tract abnormalities, primary ovarian insufficiency, hypothalamic or pituitary disorders, other endocrine gland disorders, sequelae of chronic disease, physiologic, or induced. The history should include menstrual onset and patterns, eating and exercise habits, presence of psychosocial stressors, body weight changes, medication use, galactorrhea, and chronic illness. Additional questions may target neurologic, vasomotor, hyperandrogenic, or thyroid-related symptoms. The physical examination should identify anthropometric and pubertal development trends. All patients should be offered a pregnancy test and assessment of serum follicle-stimulating hormone, luteinizing hormone, prolactin, and thyroid-stimulating hormone levels. Additional testing, including karyotyping, serum androgen evaluation, and pelvic or brain imaging, should be individualized. Patients with primary ovarian insufficiency can maintain unpredictable ovary function and may require hormone replacement therapy, contraception, or infertility services. Functional hypothalamic amenorrhea may indicate disordered eating and low bone density. Treatment should address the underlying cause. Patients with polycystic ovary syndrome should undergo screening and intervention to attenuate metabolic disease and endometrial cancer risk. Amenorrhea can be associated with clinically challenging pathology and may require lifelong treatment. Patients will benefit from ample time with the clinician, sensitivity, and emotional support.

Entities:  

Mesh:

Year:  2019        PMID: 31259490

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  12 in total

Review 1.  Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article.

Authors:  Nahid Sarahian; Mahsa Noroozzadeh; Marzieh Saei Ghare Naz; Narges Eskandari-Roozbahani; Fatemeh Mahboobifard; Fahimeh Ramezani Tehrani
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

Review 2.  Case Report: Hypothalamic Amenorrhea Following COVID-19 Infection and Review of Literatures.

Authors:  Paolo Facondo; Virginia Maltese; Andrea Delbarba; Ilenia Pirola; Mario Rotondi; Alberto Ferlin; Carlo Cappelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

3.  Evaluation and management of amenorrhea related to congenital sex hormonal disorders.

Authors:  Ju Young Yoon; Chong Kun Cheon
Journal:  Ann Pediatr Endocrinol Metab       Date:  2019-09-30

4.  Misdiagnosis of Mullerian agenesis in a patient with 46, XX gonadal dysgenesis: a missed opportunity for prevention of osteoporosis.

Authors:  Yotsapon Thewjitcharoen; Veekij Veerasomboonsin; Soontaree Nakasatien; Sirinate Krittiyawong; Thep Himathongkam
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-12-06

5.  Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites.

Authors:  Mark Newman; Desmond A Curran
Journal:  BMC Chem       Date:  2021-03-15

6.  Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.

Authors:  Fabio Pigozzi; Xavier Bigard; Juergen Steinacker; Bernd Wolfarth; Victoriya Badtieva; Christian Schneider; Jeroen Swart; James Lee John Bilzon; Demitri Constantinou; Michiko Dohi; Luigi Di Luigi; Chiara Fossati; Norbert Bachl; Guoping Li; Theodora Papadopoulou; Maurizio Casasco; Dina Christina Christa Janse van Rensburg; Jean-François Kaux; Sandra Rozenstoka; Jose-Antonio Casajus; Irina Zelenkova; Emre Ak; Bulent Ulkar; Francisco Arroyo; Anca Ionescu; André Pedrinelli; Mike Miller; Patrick Singleton; Malav Shroff; Nick Webborn; James Barrett; Blair Hamilton; Michael Geistlinger; Gianfranco Beltrami; Sergio Migliorini; Lenka Dienstbach-Wech; Stéphane Bermon; Yannis P Pitsiladis
Journal:  BMJ Open Sport Exerc Med       Date:  2022-01-18

7.  Predictive Value of Homeostasis Model Assessment of Insulin Resistance, Visceral Fat Index, and Prepregnancy Body Mass Index in Gestational Metabolic Syndrome.

Authors:  Laiping Zhao; Lichun Huang
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-24       Impact factor: 2.629

8.  The Female Athlete Triad-the impact of running and type of diet on the regularity of the menstrual cycle assessed for recreational runners.

Authors:  Joanna Witkoś; Magdalena Hartman-Petrycka
Journal:  PeerJ       Date:  2022-03-02       Impact factor: 2.984

9.  Risk of Low Energy Availability among Female and Male Elite Runners Competing at the 26th European Cross-Country Championships.

Authors:  Filipe Jesus; Inês Castela; Analiza M Silva; Pedro A Branco; Mónica Sousa
Journal:  Nutrients       Date:  2021-03-07       Impact factor: 5.717

10.  Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis.

Authors:  Karoline Aalberg; Knut Stavem; Frode Norheim; Michael Bjørn Russell; Aleksander Chaibi
Journal:  BMJ Open Sport Exerc Med       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.